| Citation: | TANG Binbin, HU Yunlian, SU Chengxia, HUANG Chaoqun, WEN Na. Study on the relationship between the nature of cold and heat of IBS-D and changes in gut microbiota and metabolites[J]. Chinese Journal of General Practice, 2025, 23(10): 1658-1662. doi: 10.16766/j.cnki.issn.1674-4152.004199 |
| [1] |
赵静丽, 赵丽丽, 陈朴, 等. 醒脾养儿颗粒联合双歧杆菌四联活菌片治疗小儿腹泻型肠易激综合征的疗效分析[J]. 中华全科医学, 2022, 20(11): 1889-1892. doi: 10.16766/j.cnki.issn.1674-4152.002728
ZHAO J L, ZHAO L L, CHEN P, et al. Efficacy of Xingpi Yanger Granule combined with bifidobacterium quadruple viable tablets in the treatment of infantile diarrhea predominant irritable bowel syndrome[J]. Chinese Journal of General Practice, 2022, 20(11): 1889-1892. doi: 10.16766/j.cnki.issn.1674-4152.002728
|
| [2] |
卞立群, 黄绍刚, 魏玮, 等. 肠易激综合征中医诊疗专家共识(2024)[J]. 中医杂志, 2024, 65(18): 1948-1956.
BIAN L Q, HUANG S G, WEI W, et al. Expert consensus on the diagnosis and treatment of irritable bowel syndrome in traditional Chinese medicine (2024)[J]. Journal of Traditional Chinese Medicine, 2024, 65(18): 1948-1956.
|
| [3] |
王永双, 李慧, 许笑梅, 等. 基于肠道菌群探讨腹泻型肠易激综合征的中西医治疗进展[J]. 现代中西医结合杂志, 2023, 32(5): 725-730.
WANG Y S, LI H, XU X M, et al. Advances in the treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese and Western medicine based on intestinal flora[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2023, 32(5): 725-730.
|
| [4] |
TANG B, HU Y, CHEN J, et al. Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome[J]. Heliyon, 2023, 9(1): e13114. DOI: 10.1016/j.heliyon.2023.e13114.
|
| [5] |
孙晗, 武侠. 成人肠易激综合征患者肠道菌群特征与不同分型患者生活质量和精神症状的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(6): 461-465.
SUN H, WU X. Correlations between gut microbiota characteristics and quality of life and psychiatric symptoms in adult irritable bowel syndrome patients with different subtypes[J]. Chinese Journal of Digestive Diseases and Imaging (Electronic Edition), 2023, 13(6): 461-465.
|
| [6] |
熊钦, 李奕霖, 姚承佼, 等. 腹泻型肠易激综合征常见证型粪便肠道菌群宏基因组学横断面研究[J]. 中医杂志, 2024, 65(5): 503-511.
XIONG Q, LI Y L, YAO C J, et al. A cross-sectional study on fecal intestinal microbiota metagenomics of common syndromes of diarrhea-predominant irritable bowel syndrome[J]. Journal of Traditional Chinese Medicine, 2024, 65(5): 503-511.
|
| [7] |
唐镔镔, 胡运莲, 文娜. 肠道菌群与腹泻型肠易激综合征中医病位病性的关系[J]. 国际中医中药杂志, 2023, 45(8): 929-934.
TANG B B, HU Y L, WEN N. Relationship between intestinal flora and location and nature of diarrheal irritable bowel syndrome in Traditional Chinese Medicine[J]. International Journal of Traditional Chinese Medicine, 2023, 45(8): 929-934.
|
| [8] |
管洁, 邓娜, 蔺晓源, 等. 腹泻型肠易激综合征及其中医病证结合动物模型的研究进展[J]. 中医药信息, 2023, 40(5): 73-78.
GUAN J, DENG N, LIN X Y, et al. Research progress on diarrhea-predominant irritable bowel syndrome and its animal model combined with traditional Chinese medicine syndromes and diseases[J]. Journal of Traditional Chinese Medicine Information, 2023, 40(5): 73-78.
|
| [9] |
李丹, 李佳, 吴松. 艾灸对脾胃虚寒型肠易激综合征大鼠肠粘膜机械屏障的影响及机制研究[J]. 针灸临床杂志, 2021, 37(3): 68-72.
LI D, LI J, WU S. Effects of moxibustion on intestinal mucosal mechanical barrier of rats with IBS of deficiency-cold of spleen and stomach[J]. Journal of Clinical Acupuncture and Moxibustion, 2021, 37(3): 68-72.
|
| [10] |
旺建伟, 王一鸣, 赵清玉, 等. 肠道微生态紊乱与肝脾不和之肠易激综合征的关联性分析[J]. 医学研究杂志, 2022, 51(3): 1-4.
WANG J W, WANG Y M, ZHAO Q Y, et al. Analysis of the correlation between intestinal microecological disorder and irritable bowel syndrome with disharmony between liver and spleen[J]. Journal of Medical Research, 2022, 51(3): 1-4.
|
| [11] |
MEI L, ZHOU J, SU Y, et al. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome[J]. BMC Gastroenterol, 2021, 21(1): 105. DOI: 10.1186/s12876-021-01693-w.
|
| [12] |
JABBAR K S, DOLAN B, EKLUND L, et al. Association between brachyspira and irritable bowel syndrome with diarrhoea[J]. Gut, 2021, 70(6): 1117-1129. doi: 10.1136/gutjnl-2020-321466
|
| [13] |
XIAO L, LIU Q, LUO M, et al. Gut microbiota-derived metabolites in irritable bowel syndrome[J]. Front Cell Infect Microbiol, 2021, 11: 729346. DOI: 10.3389/fcimb.2021.729346.
|
| [14] |
石媛嫄, 侯琳, 张丽, 等. 微生物代谢产物在肠-脑轴中作用机制研究进展[J]. 青岛大学学报(医学版), 2021, 57(3): 470-474.
SHI Y Y, HOU L, ZHANG L, et al. Research progress on the mechanism of action of microbial metabolites in the gut-brain axis[J]. Journal of Qingdao University (Medical Edition), 2021, 57(3): 470-474.
|
| [15] |
SMOLINSKA S, WINIARSKA E, GLOBINSKA A, et al. Histamine: a mediator of intestinal disorders: a review[J]. Metabolites, 2022, 12(10): 895. DOI: 10.3390/metabo12100895.
|
| [16] |
蔡方红, 达静静, 俞洋, 等. 泛酸激酶与线粒体功能障碍相关疾病关系的研究进展[J]. 中华医学杂志, 2024, 104(2): 163-166.
CAI F H, DA J J, YU Y, et al. Research progress on the relationship between pantothenate kinase and diseases related to mitochondrial dysfunction[J]. National Medical Journal of China, 2024, 104(2): 163-166.
|
| [17] |
CHOJNACKI C, BLONSKA A, KONRAD P, et al. Changes in tryptophan metabolism on serotonin and kynurenine pathways in patients with irritable bowel syndrome[J]. Nutrients, 2023, 15(5): 1262. DOI: 10.3390/nu15051262.
|
| [18] |
CHOJNACKI C, KONRAD P, BŁOÑSKA A, et al. Altered tryptophan metabolism on the kynurenine pathway in depressive patients with small intestinal bacterial overgrowth[J]. Nutrients, 2022, 14(15): 3217. DOI: 10.3390/nu15051262.
|
| [19] |
岑水梅, 邹颖, 曾家炀, 等. 黄芩汤通过调节色氨酸代谢激活AhR修复溃疡性结肠炎肠道屏障的作用机制研究[J]. 中国中药杂志, 2024, 49(20): 5555-5565.
CAI F H, DA J J, YU Y, et al. Mechanism of Huangqin Decoction in repairing intestinal barrier of ulcerative colitis by regulating tryptophan metabolism and activating AhR[J]. China Journal of Chinese Materia Medica, 2024, 49(20): 5555-5565.
|
| [20] |
GASALY N, DE VOS P, HERMOSO M A. Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation[J]. Front Immunol, 2021, 12: 658354. DOI: 10.3389/fimmu.2021.658354.
|
| [21] |
SZELEST M, WALCZAK K, PLECH T. A new insight into the potential role of tryptophan-derived AhR ligands in skin physiological and pathological processes[J]. Int J Mol Sci, 2021, 22(3): 1104. DOI: 10.3390/ijms22031104.
|
| [22] |
SCOTT S A, FU J, CHANG P V. Dopamine receptor D2 confers colonization resistance via microbial metabolites[J]. Nature, 2024, 628(8006): 180-185. doi: 10.1038/s41586-024-07179-5
|
| [23] |
LV W J, MA Y M, HUANG J Y, et al. Polysaccharides derived from Shenling Baizhu San improve colitis via modulating tryptophan metabolism in mice[J]. Int J Biol Macromol, 2022, 222(Pt A): 1127-1136.
|